- Home
- GERN vs GSBC Comparison
GERN vs GSBC Comparison
Compare GERN & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- GSBC
- Stock Information
- Founded
- GERN 1990
- GSBC 1923
- Country
- GERN United States
- GSBC United States
- Employees
- GERN N/A
- GSBC N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- GSBC Major Banks
- Sector
- GERN Health Care
- GSBC Finance
- Exchange
- GERN Nasdaq
- GSBC Nasdaq
- Market Cap
- GERN 823.0M
- GSBC 676.3M
- IPO Year
- GERN 1996
- GSBC N/A
- Fundamental
- Price
- GERN $1.38
- GSBC $61.20
- Analyst Decision
- GERN Buy
- GSBC Hold
- Analyst Count
- GERN 7
- GSBC 2
- Target Price
- GERN $3.17
- GSBC $60.50
- AVG Volume (30 Days)
- GERN 6.7M
- GSBC 35.4K
- Earning Date
- GERN 11-06-2025
- GSBC 10-15-2025
- Dividend Yield
- GERN N/A
- GSBC 2.61%
- EPS Growth
- GERN N/A
- GSBC 17.24
- EPS
- GERN N/A
- GSBC 5.86
- Revenue
- GERN $164,447,000.00
- GSBC $224,299,000.00
- Revenue This Year
- GERN $175.15
- GSBC N/A
- Revenue Next Year
- GERN $56.61
- GSBC N/A
- P/E Ratio
- GERN N/A
- GSBC $10.45
- Revenue Growth
- GERN 11877.20
- GSBC 4.82
- 52 Week Low
- GERN $1.09
- GSBC $47.58
- 52 Week High
- GERN $4.50
- GSBC $68.02
- Technical
- Relative Strength Index (RSI)
- GERN 44.59
- GSBC N/A
- Support Level
- GERN $1.26
- GSBC N/A
- Resistance Level
- GERN $1.48
- GSBC N/A
- Average True Range (ATR)
- GERN 0.07
- GSBC 0.00
- MACD
- GERN -0.00
- GSBC 0.00
- Stochastic Oscillator
- GERN 13.64
- GSBC 0.00
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.